Animal Sedative Market by Type and Geography - Forecast and Analysis 2022-2026

The animal sedative market share is expected to increase by USD 190.96 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 5.85%.

This animal sedative market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers animal sedative market segmentation by type (parenteral and oral) and geography (North America, Europe, Asia, and Rest of World (ROW)). The animal sedative market report also offers information on several market vendors, including Akorn Operating Co. LLC, AmerisourceBergen Corp, Bayer AG, Bimeda Inc., C. H. Boehringer Sohn AG and Co. KG, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Jurox Pty Ltd., Konig SA, Laboratorios Richmond, Merck KGaA, Modern Veterinary Therapeutics LLC, Randlab Pty Ltd., Troy Laboratories Pty Ltd., Virbac Group, Zoetis Inc., Orion Corp., and Ouro Fino Saude Animal Group among others.

What will the Animal Sedative Market Size be During the Forecast Period?

Download Report Sample to Unlock the Animal Sedative Market Size for the Forecast Period and Other Important Statistics

 

Animal Sedative Market: Key Drivers, Trends, and Challenges

The increasing prevalence of animal diseases is notably driving the animal sedative market growth, although factors such as stringent government regulations may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the animal sedative industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Animal Sedative Market Driver

One of the key factors driving growth in the animal sedative market is the increasing prevalence of animal diseases. Globally zoonotic diseases, brucellosis, bacterial parasites, cancer, and food-borne diseases are becoming more common in animals. In tropical and subtropical nations, parasitic diseases are one of the major obstacles that place a significant socioeconomic burden on the livestock industry. There are a variety of factors that are contributing to the rise in disease prevalence and influencing the health of the pet population. The most common disorders diagnosed in canine and feline populations are obesity, diabetes, and heartworm disease. Diabetes Mellitus is a long-term condition that necessitates lifelong treatment, medicine, and careful monitoring. Infectious diseases in animals, Atrophic rhinitis, bluetongue, bovine spongiform encephalopathy (BSE), avian influenza, swine influenza, and bovine diarrhea are pathogenic illnesses in animals. As a result, rising concerns about health disorders in animals boost the global animal sedative market growth.

Key Animal Sedative Market Trend

The increasing adoption of pet animals is an animal sedative market trend that is expected to have a positive impact in the coming years. Pet ownership and populations have grown, presenting chances for veterinary practices to expand profitability. The COVID-19 pandemic's effects were barely evident in the results. In 2020, people who work from home were eight times more likely to have a new pet. Pet ownership has been associated with lower blood pressure, reduced stress, a lower risk of heart disease, and lower overall health care expenses in recent studies. Companion animals, in summary, make people happier and healthier. For instance, according to a poll of pet owners conducted in 2021, 69 million homes in the US possessed at least one dog, making dogs the most popular type of pet in the country. Thus, the increase in ownership of companion animals contributed to the global animal sedative market growth and is expected to continue.

Key Animal Sedative Market Challenge

The stringent government regulations will be a major challenge for the animal sedative market during the forecast period. The FDA regulates animal medicines in the same way that it regulates human medicines. Animal medicines must go through the same stringent approval processes as human medicines before they may be made or commercialized. Animal medicines are still subject to tight rules that safeguard animals, humans, and the environment after enduring rigorous research and approval processes. Animal medicines are extensively researched and tested for safety, purity, and efficacy while awaiting clearance, a process that can take five to seven years and cost tens of millions of dollars. Animal medicines are regulated by the government at all levels. These regulations may reduce new organizations from entering the market thereby hindering the global animal sedative market growth.

This animal sedative market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global animal sedative market as a part of the global pharmaceuticals market within the overall healthcare industry. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the animal sedative market during the forecast period.

Who are the Major Animal Sedative Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

• Akorn Operating Co. LLC
• AmerisourceBergen Corp
• Bayer AG
• Bimeda Inc.
• C. H. Boehringer Sohn AG and Co. KG
• Ceva Sante Animale
• Chanelle Pharma Group
• Dechra Pharmaceuticals Plc
• Elanco Animal Health Inc.
• Jurox Pty Ltd.
• Konig SA
• Laboratorios Richmond
• Merck KGaA
• Modern Veterinary Therapeutics LLC
• Randlab Pty Ltd.
• Troy Laboratories Pty Ltd.
• Virbac Group
• Zoetis Inc.
• Orion Corp.
• Ouro Fino Saude Animal Group

 

This statistical study of the animal sedative market encompasses successful business strategies deployed by the key vendors. The animal sedative market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

• Bayer AG - Bayer AG is a public company headquartered in Germany. It is a global company generating $49,926.14 million in revenues and has around 99,637 employees. Its revenue from the global animal sedative market contributes to its overall revenues along with its other offerings, but it is not a key revenue stream for the company. 
• Bayer AG - The company offers animal sedatives such as Rompun. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The animal sedative market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Animal Sedative Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the animal sedative market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Animal Sedative Market?

For more insights on the market share of various regions Request PDF Sample now!

44% of the market’s growth will originate from North America during the forecast period. US and Canada are the key markets for animal sedatives in North America. Market growth in this region will be faster than the growth of the market in the European and ROW regions.

The increase in pet ownership and animal healthcare spending in the region will facilitate the animal sedative market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The emergence of COVID-19 in 2020 had a negative impact on all countries in North America, particularly in the US. The pandemic had an impact on the healthcare sector through both financial struggles and reduced business production capacity. The demand for veterinary research services increased as the number of COVID-19 cases increased in 2020. Cost constraints in the overall animal healthcare industry, owing to the pandemic's economic slowdown, limited veterinary companies' R and D finances, leading them to outsource these efforts to veterinary CROs, hence supporting market growth. 

What are the Revenue-generating Type Segments in the Animal Sedative Market?

To gain further insights on the market contribution of various segments Request PDF Sample

The animal sedative market share growth by the parenteral segment will be significant during the forecast period. Parenteral administration methods typically produce the highest bioavailability of drugs as they avoid the first-pass effect of hepatic metabolism, which frequently happens with orally delivered chemicals and medicines. Additionally, some of the uncertainty involved with enteral absorptive processes is avoided by using parenteral methods. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the animal sedative market size and actionable market insights on post COVID-19 impact on each segment.

 

Animal Sedative Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 5.85%
Market growth 2022-2026	$ 190.96 million
Market structure	Fragmented
YoY growth (%)	5.25
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 44%
Key consumer countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Akorn Operating Co. LLC, AmerisourceBergen Corp, Bayer AG, Bimeda Inc., C. H. Boehringer Sohn AG and Co. KG, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Jurox Pty Ltd., Konig SA, Laboratorios Richmond, Merck KGaA, Modern Veterinary Therapeutics LLC, Randlab Pty Ltd., Troy Laboratories Pty Ltd., Virbac Group, Zoetis Inc., Orion Corp., and Ouro Fino Saude Animal Group
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Animal Sedative Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive animal sedative market growth during the next five years
• Precise estimation of the animal sedative market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the animal sedative industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of animal sedative market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch